These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 21439496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation.
    Buxton AE, Ellison KE, Lorvidhaya P, Ziv O.
    J Cardiovasc Pharmacol; 2010 May; 55(5):450-5. PubMed ID: 20509178
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.
    Arch Intern Med; 2009 Sep 14; 169(16):1500-6. PubMed ID: 19752408
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sudden death prophylaxis in heart failure.
    Rosanio S, Schwarz ER, Vitarelli A, Zarraga IG, Kunapuli S, Ware DL, Birnbaum Y, Tuero E, Uretsky BF.
    Int J Cardiol; 2007 Jul 31; 119(3):291-6. PubMed ID: 17208319
    [Abstract] [Full Text] [Related]

  • 7. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
    Paolucci M, Cattafi G, Magenta G, Vecchi MR, Schirru M, Lunati M.
    G Ital Cardiol (Rome); 2008 Oct 31; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
    [Abstract] [Full Text] [Related]

  • 8. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP.
    Am Fam Physician; 2010 Dec 01; 82(11):1357-66. PubMed ID: 21121520
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?
    Santangeli P, Dello Russo A, Casella M, Pelargonio G, Di Biase L, Natale A.
    Intern Med J; 2011 Jan 01; 41(1a):55-60. PubMed ID: 21265961
    [Abstract] [Full Text] [Related]

  • 10. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J, Chatellier G, Le Heuzey JY, Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators.
    Am Heart J; 2009 Feb 01; 157(2):391-397.e1. PubMed ID: 19185651
    [Abstract] [Full Text] [Related]

  • 11. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L, Hua W, Niu H, Chen K, Zhang S.
    Europace; 2008 Sep 01; 10(9):1034-41. PubMed ID: 18559335
    [Abstract] [Full Text] [Related]

  • 12. Primary prevention of sudden cardiac death. do we need to implant a defibrillator in all the patients with low ejection fraction?
    Disertori M, El-Sherif N.
    Ital Heart J; 2004 Sep 01; 5(9):643-7. PubMed ID: 15568590
    [No Abstract] [Full Text] [Related]

  • 13. [Arrhythmia risk stratification in patients with heart failure. Foreword].
    Opasich C, Santini M.
    Ital Heart J Suppl; 2001 Dec 01; 2(12):1263-4. PubMed ID: 11838345
    [Abstract] [Full Text] [Related]

  • 14. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
    Disertori M, Quintarelli S, Mazzola S, Favalli V, Narula N, Arbustini E.
    Europace; 2013 Dec 01; 15(12):1693-701. PubMed ID: 23946316
    [Abstract] [Full Text] [Related]

  • 15. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
    Botto GL, Proclemer A, Luzi M, Ruffa F, Gorgoglione MG, Ferrari G.
    Ital Heart J; 2005 Mar 01; 6(3):210-5. PubMed ID: 15875511
    [Abstract] [Full Text] [Related]

  • 16. Identifying the high risk patient with coronary artery disease--is ejection fraction all you need?
    Buxton AE.
    J Cardiovasc Electrophysiol; 2005 Sep 01; 16 Suppl 1():S25-7. PubMed ID: 16138881
    [Abstract] [Full Text] [Related]

  • 17. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
    Kamath GS, Mittal S, Sherrid MV.
    Anadolu Kardiyol Derg; 2009 Dec 01; 9 Suppl 2():32-40. PubMed ID: 20089485
    [Abstract] [Full Text] [Related]

  • 18. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO, Hellkamp AS, Ellenbogen KA, Lamas GA.
    J Cardiovasc Electrophysiol; 2008 Nov 01; 19(11):1160-6. PubMed ID: 18554201
    [Abstract] [Full Text] [Related]

  • 19. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML, MADIT-II Investigators.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):288-96. PubMed ID: 18206738
    [Abstract] [Full Text] [Related]

  • 20. Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.
    Atary JZ, Borleffs CJ, Liem SS, Bax JJ, van der Hoeven BL, Bootsma M, van der Wall EE, van Erven L, Schalij MJ.
    Europace; 2010 Mar 22; 12(3):378-84. PubMed ID: 20056593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.